AstraZeneca and Johnson & Johnson get go-ahead from Food and Drug Administration after pausing studies when volunteers became ill
Two drugmakers have announced the resumption of US testing of their Covid-19 vaccine candidates.
Testing of AstraZeneca’s vaccine candidate had been halted since early September, while Johnson & Johnson’s vaccine study was paused at the beginning of last week. Each company had a study volunteer develop a serious health issue, requiring a review of safety data.
Related Posts
Solving problems is better than fearmongering
Windows adds support for RAR, Netflix cracks down on passwords, and Meta lays off workers
Startups should absolutely work with governments to support defense projects
3 Views on a16z’s latest reported early-stage effort
